Pharmacists in Southbury, Connecticut


13 Pharmacists found in Southbury
male pharmacist

Dr. Adam Michael Mastroianni, PHARMD


Pharmacist
377 Chestnut Tree Hill Rd, Southbury, CT 06488
203-819-1213    

female pharmacist

Ms. Amy M Jodlowski, RPH


Pharmacist
370 Main St S, Southbury, CT 06488
203-267-6718     203-267-6723

male pharmacist

Andrew John Christensen, PHARMD


Pharmacist
370 Main St S, Southbury, CT 06488
203-267-6718    



male pharmacist

Andrew Perugini


Pharmacist
100 Main St N, Southbury, CT 06488
203-262-4559    

female pharmacist

Andria Latifi


Pharmacist
370 Main St S, Southbury, CT 06488
203-267-6718    

female pharmacist

Hatali Amrut Patel, PHARMD


Pharmacist
200 Main St S, Southbury, CT 06488
203-262-8000    

male pharmacist

Jared Laviano, RPH


Pharmacist
22 Depot Hill Rd, Southbury, CT 06488
203-262-1831    

male pharmacist

Mr. John Philip Gribbin Sr., RPH


Pharmacist
100 Main St N, Southbury, CT 06488
203-262-4559     844-411-6435

female pharmacist

Masooma R Khan, RPH


Pharmacist
22 Depot Hill Rd, Southbury, CT 06488
203-262-1831    

female pharmacist

Ms. Megan Elizabeth Parsi, PHARM D


Pharmacist
370 Main St S, Southbury, CT 06488
203-267-6718    

male pharmacist

Ryan Lamphere


Pharmacist
775 Main St S, Southbury, CT 06488
203-267-7422    

male pharmacist

Dr. Thomas John Karvosky, PHARMD


Pharmacist - Pharmacotherapy
22 Depot Hill Rd, Southbury, CT 06488
203-262-1831    

male pharmacist

Mr. Walter A Karwon, RPH


Pharmacist
370 Main St S, Southbury, CT 06488
203-267-6718    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.